Changes in glutathione-related enzymes in tumor-bearing mice after cisplatin treatment

Cell Biology and Toxicology

Volumn 18, Issue 6, 2002, Pages 349-358

  Khynriam, D ^a   Prasad, Surya B ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Catalase; Cisplatin; Dalton lymphoma; Glutathione; Glutathione peroxidase; Glutathione reductase; Glutathione S transferase; Superoxide dismutase

Indexed keywords

CISPLATIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE; ANTINEOPLASTIC AGENT; GLUTATHIONE REDUCTASE; PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; LYMPHOMA CELL; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; ENZYMOLOGY; KIDNEY; LIVER; LYMPHOMA; METABOLISM; PATHOLOGY;

ANIMALIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; KIDNEY; LIVER; LYMPHOMA; MALE; MICE; PEROXIDASES; SUPEROXIDE DISMUTASE; TUMOR CELLS, CULTURED;

EID: 0036436924     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020899221192     Document Type: Article

References (50)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6.
2. Arruda VR, Salles TSI, Costa FF, Sead STO. Glutathione peroxidase, reduced glutathione, superoxide dismutase and catalase in red cells of patient with hairy cells leukemia. Neoplasma. 1996;43:99-102.
3. Black SM, Wolf CR. The role of glutathione-dependent enzymes in drug resistance. Pharmacol Ther. 1991;51:139-54.
4. Canada AT, Herman L, Kidd K, Robertson C, Trump D. Glutathione depletion increases the cytotoxicity of melphalan to the androgen-insensitive prostate cancer cell lines. Cancer Chemother Pharmacol. 1993;32:73-7.
5. Chien C, Kirollos KS, Linderman RJ, Dauterman WC. α,β-Unsaturated carbonyl compounds: Inhibition of rat liver glutathione S-transferase isozymes and chemical reaction with reduced glutathione. Biochim Biophys Acta. 1994; 1204:175-80.
6. Collins JL, Kao M. The anticancer drug cisplatin increases the naturally occuring cell-mediated lysis of tumor cells. Cancer Immunol Immunother. 1989;29:17-22.
7. Corrocher R, Casaril M, Bellisola G, et al. Severe impairment of antioxidant system in human hepatoma. Cancer. 1986; 58:1658-62.
8. Coste F, Malinge J, Serra L, et al. Crystal structure of a doublestranded DNA containing a cisplatin intrastrand cross-link at 1.63 Å resolution-hydration at the platinated site. Nucleic Acids Res. 1999;27:1837-46.
9. Deleve LG, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther. 1991;52:287-305.
10. Flohe L, Gunzler WA. Assay of glutathione peroxidase. Methods Enzymol. 1984;105:114-21.
11. Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol. 1984;105:93-104.
12. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64:97-112.
13. Giri A, Khynriam D, Prasad SB. Vitamin C mediated protection on cisplatin induced mutagenicity in mice. Mutation Res. 1998a;421:139-48.
14. Giri A, Khynriam D, Prasad SB. Use of vitamin C against cisplatin induced mutagenicity and nephrotoxicity. In: Sharan R, ed, Trends in radiation and cancer biology. Vol. 29. Germany: Forschungszentrum Julich; 1998b:166-76.
15. Go RS, Adjei AA. Review of comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol. 1999;17:409-22.
16. Gromadzinska J, Wasowicz W, Andrijewski M, et al. Glutathione and glutathione metabolizing enzymes in tissues and blood of breast cancer patients. Neoplasma. 1997;44: 45-51.
17. Habig WH, Pabot MJ, Jarkoby WB. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130-9.
18. Hansson J, Berhane K, Castro VM, Jungnelius U, Mannervik B, Ringborg U. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res. 1991;51:94-8.
19. Hayes JD, Pulford DJ. The glutathione S-transferase super gene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445-600.
20. Ishikawa T, Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells: Molecular characterization of glutathione platinum complex and its biological significance. J Biol Chem. 1993;268:20116-25.
21. Jones MM, Basinger MA. Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinoma. Anticancer Res. 1989;9:1937-42.
22. Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res. 2001;478:23-43.
23. Kharbangar A, Khynriam D, Prasad SB. Effect of cisplatin on mitochondrial protein, glutathione and succinate dehydrogenase activity. Cell Biol Toxicol. 2000;16:363-73.
24. Khynriam D, Prasad SB. Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice. Cell Biol Toxicol. 2001;17:357-70.
25. Kodera Y. Isobe K, Yamauchi M, et al. Expression of glutathione S-transferases α and π in gastric cancer: A correlation with cisplatin resistance. Cancer Chemother Pharmacol. 1994;34:203-8.
26. Krakoff IH. Nephrotoxicity of cis-dichlorodiammineplatinum. Cancer Treat Rep. 1979;63:1523-5.
27. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
28. Meister A. Glutathione deficiency produced by inhibition of its synthesis and its reversal: Application in research and therapy. Pharmacol Ther. 1991;51:155-94.
29. Nakano S, Gemba M. Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J Pharmacol. 1989;50:87-92.
30. Navarro J, Obrador E, Carretero J, et al. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med. 1999;26:410-18.
31. Ohkuwa T, Sato Y, Naoi M. Glutathione status and reactive oxygen generation in tissues of young and old exercised rats. Acta Physiol Scand. 1997;159:237-44.
32. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol. 1990;186:209-21.
33. Prasad SB, Giri A. Antitumour effect of cisplatin against murine ascites Dalton's lymphoma. Indian J Exp Biol. 1994;32:155-62.
34. Prasad SB, Giri A. Cisplatin-induced changes in tissue calcium and potassium concentrations in tumour-bearing mice. Med Sci Res. 1999;27:459-62.
35. Prasad SB, Sodhi A. Effect of cis-dichlorodiammineplatinum(II) on the agglutinability of tumor and normal cells with concanavalin A and wheat germ agglutinin. Chem Biol Interact. 1981;36:355-67.
36. Prasad SB, Giri A, Khynriam D, Kharbangar A, Nicol BM, Lotha C. Cisplatin-mediated enzymatic changes in mice bearing ascites Dalton's lymphoma. Med Sci Res. 1999;27: 723-30.
37. Rosenberg B. Fundamental studies with cisplatin. Cancer. 1985;55:2303-16.
38. Sadzuka Y, Shoji T, Takino Y. Change of lipid peroxide levels in rat tissues after cisplatin administration. Toxicol Lett. 1991; 57:159-66.
39. Sedlak J, Lindsay RH. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25:192-205.
40. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med. 1999;27:916-21.
41. Slater TF. Free radical mechanism in tissue injury. Biochem J. 1984;222:1-15.
42. Smith IK, VierHeller TL, Thorne CA. Assay of glutathione reductase in crude tissue homogenate using 5,5′-dithiobis(2-nitrobenzoic acid). Anal Biochem. 1988;175:408-13.
43. Sweet WL, Blanchard JS. Human erythrocyte glutathione reductase: Chemical mechanism and structure of the transition state for hydride transfer. Biochem. 1991;30:8702-9.
44. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991; 51:794-8.
45. Teramato S, Tomita T, Matsui H, Ohga E, Matsuse T, Ouchi Y. Hydrogen peroxide-induced apoptosis and necrosis in human lung fibroblasts: Protective roles of glutathione. Jpn J Pharmacol. 1999;79:33-40.
46. Tew KD. Glutathione associated enzymes in anticancer drug resistance. Cancer Res. 1994;54:4313-20.
47. Tew KD, Bomber AM, Hoffman, SJ. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. 1988;48:3622-5.
48. Ueda M, Mozaffar S, Tanaka A. Catalase from Candida boidini 2201. Methods Enzymol. 1990;188:463-7.
49. Wang W, Ballatori N. Endogenous glutathione conjugates: Occurrence and biological functions. Pharmacol Rev. 1998;50:335-55.
50. Zwelling LA, Anderson T, Kohn KW. DNA-protien and DNA inter-strand cross-linking by cis- and trans-platinum(II) diamminedichloride in 1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res. 1979;39:365-9.